Announcements Trials
Browse Landscape

Phase

Phase 1/2 1

Status

Completed 1

Sponsor Class

INDUSTRY 1

Study Type

Interventional 1

Sponsor

Cancer Type

Thoracic 1Sarcoma 1Gastrointestinal 1Dermatologic 1Breast 1

Conditions

Sarcoma 16Central Nervous System Neoplasms 10Gliosarcoma 9Glioblastoma 9Osteosarcoma 8Astrocytoma 6Sarcoma, Ewing 5Neoplasms 4Precursor Cell Lymphoblastic Leukemia-Lymphoma 3Lymphoma 3Lung Neoplasms 3Breast Neoplasms 3Brain Neoplasms 3Waldenstrom Macroglobulinemia 2Stomach Neoplasms 2Recurrence 2Pancreatic Neoplasms 2Ovarian Neoplasms 2Oligodendroglioma 2Neoplasm Metastasis 2Multiple Myeloma 2Melanoma 2Lymphoma, Extranodal NK-T-Cell 2Liver Neoplasms 2Leukemia, Myelomonocytic, Juvenile 2Leukemia 2Glioma 2Esophageal Neoplasms 2Dendritic Cell Sarcoma, Interdigitating 2Colorectal Neoplasms 2

Interventions

Imatinib Mesylate 71Sunitinib 31regorafenib 17nilotinib 15ripretinib 13avapritinib 7Laparoscopy 5Ipilimumab 5Dasatinib 5spartalizumab 4CTLA-4 Antigen 4Blood Specimen Collection 44-amino-5-fluoro-3-(5-(4-methylpiperazin-1-yl)-1H-benzimidazol-2-yl)quinolin-2(1H)-one 4pexidartinib 3pazopanib 3binimetinib 3Temozolomide 3Surveys and Questionnaires 3Surgical Procedures, Operative 3Paclitaxel 3Oxaliplatin 3Observation 3Nivolumab 3Midazolam 3Leucovorin 3Gemcitabine 3Biopsy 3Bevacizumab 3trametinib 2tanespimycin 2

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Gastrointestinal Stromal Tumors × Drug Therapy × Sarcoma × Clear all
NCT00041808 2005-06-24

Magnetic-Targeted Doxorubicin in Treating Patients With Cancer Metastatic to the Liver

FeRx

Phase 1/2 Completed
20 enrolled
BreastDermatologicGastrointestinalSarcomaThoracic

Breast Neoplasms, Esophageal Neoplasms, Gastrointestinal Neoplasms, Liver Neoplasms, Lung Neoplasms, Melanoma, Neoplasm Metastasis, Pancreatic Neoplasms, Sarcoma, Stomach Neoplasms, Colorectal Neoplasms, Cholangiocarcinoma, Gastrointestinal Stromal Tumors

Data powered by HemOnc (CC BY 4.0) Colophon âš¡